AstraZeneca's COVID-19 vaccine shows midphase promise in seniors

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 19, 2020 at 11:13 AM.

  1. #1 cafead, Nov 19, 2020 at 11:13 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via A phase 2 clinical trial has found AstraZeneca’s COVID-19 vaccine delivers similar immune responses in people aged over and under 70 years. The update, which suggests the vaccine is better tolerated by seniors, provides further evidence that prophylactics may work in the people most vulnerable to the coronavirus.

    article source
     
    Quote

Reply to Thread